Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.175 AUD | 0.00% | -5.41% | -2.78% |
23/04 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
10/04 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.78% | 51.79M | |
-16.58% | 8.44B | |
+58.10% | 3.96B | |
-39.78% | 2.52B | |
-10.33% | 2.44B | |
-8.91% | 2.22B | |
-4.11% | 1.98B | |
-19.62% | 1.58B | |
-38.30% | 1.3B | |
+2.19% | 1.05B |
- Stock Market
- Equities
- MAP Stock
- News Microba Life Sciences Limited
- Microba Life Sciences Validates Safety, Tolerability of Inflammatory Bowel Disease Therapy in Phase One Trial